Tailoring Messages to the U.S. Latinx Community

Code Switch The president of the Latino Commission on AIDS talks about tailoring messages to U.S. Latinos by Larry Buhl In early September in Philadelphia, NMAC (formerly...

UFO Plan Meets IDUs

Finger on the Pulse The UFO Plan meets young IV drug users where they are by Larry Buhl Hepatitis prevention and treatment efforts depend on outreach. For...

Curing Hep B

C2B The success in curing hep C fuels race to cure B by Larry Buhl In 2013, a revolution happened: A drug regimen was developed that could...

Dos & Dont’s

Hep C Is Manageable—If You Know the Ins and Outs by Larry Buhl You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...

Hep Community: We Need More Federal Dollars

Money Talks The hepatitis community wants more federal dollars; hep a cases rising fast by Larry Buhl Here’s the good news on federal funding for hepatitis research...

Care Costs

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

HCV Under the Radar

It’s desk-clearing time for 2015 and time to visit some under-reported hepatitis C-related news. Hep C has been in the news quite a bit...

African Americans & HCV

"Race" Matters Researchers study disparities when it comes to African Americans & HCV by Larry Buhl               A growing number of clinicians and researchers want the African-American community...

Is Mass HCV Screening the Best Approach?

LifeGuide Calling All Boomers New analysis questions the need for mass HCV screening by Larry Buhl In 2012, the U.S. Centers for Disease Control and Prevention (CDC) recommended...

Do One Thing

With new, game-changing hepatitis C meds available or in the pipeline, an emerging issue is how to find at-risk patients, get them screened and...

LATEST POSTS

Ron B: Cover Story

“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...